Literature DB >> 10219252

Cytokine-induced calgranulin C expression in keratocytes.

J D Gottsch1, Q Li, F Ashraf, T P O'Brien, W J Stark, S H Liu.   

Abstract

The authors have identified a corneal stromal protein (CO-Ag) that may be involved in the pathogenesis of Mooren's ulcer. The CO-Ag cDNA sequence is identical to that of human neutrophil calgranulin C (CaGC). This study sought to demonstrate expression of the CaGC gene in the human cornea and in corneal keratocytes after cytokine stimulation. In situ hybridization and immunohistochemistry were used to localize CaGC mRNA and protein in normal and diseased human corneas, including a specimen with Mooren's ulcer. Cultured bovine keratocytes were stimulated with IL-1 alpha or TNF-alpha, and reverse transcription polymerase chain reaction (RT-PCR) was performed to amplify CaGC cDNA from cytokine-stimulated keratocytes and unstimulated controls. Southern blotting verified the specificity of the RT-PCR amplification products. In situ hybridization detected human CaGC mRNA in the stroma of corneas with Fuchs' dystrophy, postinfection corneas, and a cornea with Mooren's ulcer. In cultured bovine keratocytes, peak levels of CaGC mRNA were reached 6 h after cytokine stimulation. Southern blots with an oligonucleotide probe specific for CaGC detected the RT-PCR products of expected sizes (273 bp) and confirmed that the amplified CO-Ag sequence was identical to that of CaGC. These studies are the first to demonstrate the presence of CaGC in the human cornea and the ability of stromal keratocytes to produce CaGC (CO-Ag). The up-regulation of CaGC gene expression by corneal keratocytes due to proinflammatory cytokines from trauma or inflammation may induce autoimmunity that ultimately results in Mooren's ulceration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219252     DOI: 10.1006/clim.1998.4681

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

2.  Epithelial regulation of mesenchymal tissue behavior.

Authors:  Corrie L Gallant-Behm; Pan Du; Simon M Lin; Philip T Marucha; Luisa A DiPietro; Thomas A Mustoe
Journal:  J Invest Dermatol       Date:  2011-01-13       Impact factor: 8.551

3.  Clinical characteristics of Mooren's ulcer in South India.

Authors:  Muthaiah Srinivasan; Michael E Zegans; Joseph R Zelefsky; Arunava Kundu; Thomas Lietman; John P Whitcher; Emmett T Cunningham
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

4.  Calgranulin C has filariacidal and filariastatic activity.

Authors:  J D Gottsch; S W Eisinger; S H Liu; A L Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 5.  The impact of metal availability on immune function during infection.

Authors:  Andrew J Monteith; Eric P Skaar
Journal:  Trends Endocrinol Metab       Date:  2021-09-03       Impact factor: 12.015

6.  The alarmin S100A12 causes sterile inflammation of the human chorioamniotic membranes as well as preterm birth and neonatal mortality in mice†.

Authors:  Kenichiro Motomura; Roberto Romero; Olesya Plazyo; Valeria Garcia-Flores; Meyer Gershater; Jose Galaz; Derek Miller; Nardhy Gomez-Lopez
Journal:  Biol Reprod       Date:  2021-12-20       Impact factor: 4.161

7.  The involvement of multipotential progenitor cells in Mooren's ulcer.

Authors:  In Gul Lee; Juan Ye; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

Review 8.  Proteomics of the amniotic fluid in assessment of the placenta. Relevance for preterm birth.

Authors:  I A Buhimschi; C S Buhimschi
Journal:  Placenta       Date:  2008-01-11       Impact factor: 3.481

9.  Clinical Characteristics and Risk Factors of Recurrent Mooren's Ulcer.

Authors:  Lixia Yang; Juan Xiao; Jiawei Wang; Han Zhang
Journal:  J Ophthalmol       Date:  2017-06-27       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.